Avid Bioservices Inc
NASDAQ:CDMO
Avid Bioservices Inc
Revenue
Avid Bioservices Inc
Revenue Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Avid Bioservices Inc
NASDAQ:CDMO
|
Revenue
$150.4m
|
CAGR 3-Years
12%
|
CAGR 5-Years
18%
|
CAGR 10-Years
21%
|
|
|
Abbvie Inc
NYSE:ABBV
|
Revenue
$56.3B
|
CAGR 3-Years
0%
|
CAGR 5-Years
11%
|
CAGR 10-Years
11%
|
|
|
Gilead Sciences Inc
NASDAQ:GILD
|
Revenue
$28.8B
|
CAGR 3-Years
2%
|
CAGR 5-Years
5%
|
CAGR 10-Years
1%
|
|
|
Amgen Inc
NASDAQ:AMGN
|
Revenue
$33.4B
|
CAGR 3-Years
9%
|
CAGR 5-Years
7%
|
CAGR 10-Years
5%
|
|
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
Revenue
$11B
|
CAGR 3-Years
13%
|
CAGR 5-Years
21%
|
CAGR 10-Years
34%
|
|
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
Revenue
$14.2B
|
CAGR 3-Years
-4%
|
CAGR 5-Years
13%
|
CAGR 10-Years
18%
|
|
Avid Bioservices Inc
Revenue Breakdown
Breakdown by Geography
Avid Bioservices Inc
Breakdown by Segments
Avid Bioservices Inc
|
Total Revenue:
139.9m
USD
|
|
Manufacturing Revenues:
119.3m
USD
|
|
Process Development Revenues:
20.6m
USD
|
Avid Bioservices Inc
Glance View
Avid Bioservices, Inc. engages in the commercial manufacturing. The company is headquartered in Tustin, California and currently employs 252 full-time employees. The firm is focused on development and Current Good Manufacturing Practices (CGMP) manufacturing of biopharmaceutical products derived from mammalian cell culture. The firm provides a range of process development, CGMP clinical and commercial manufacturing services for the biotechnology and biopharmaceutical industries. The Company’s services include CGMP clinical and commercial product manufacturing, purification, bulk packaging, stability testing and regulatory strategy, submission and support. The firm also provides process development activities, including cell line development and optimization, cell culture and feed optimization, analytical methods development and product characterization.
See Also
What is Avid Bioservices Inc's Revenue?
Revenue
150.4m
USD
Based on the financial report for Oct 31, 2024, Avid Bioservices Inc's Revenue amounts to 150.4m USD.
What is Avid Bioservices Inc's Revenue growth rate?
Revenue CAGR 10Y
21%
Over the last year, the Revenue growth was -16%. The average annual Revenue growth rates for Avid Bioservices Inc have been 12% over the past three years , 18% over the past five years , and 21% over the past ten years .
You don't have any saved screeners yet